Range
2.57 - 2.66
Vol / Avg.
1.3M/13.2M
Div / Yield
-
52 Wk
2.06 - 8.75
Mkt Cap
74.1M
Payout Ratio
-
Open
2.65
P/E
-
EPS
-0.45
Shares
28.6M
Outstanding
28.6M
Total Float
28.3M
load more
Sector: Health Care.Industry: Health Care Equipment & Supplies
Chembio Diagnostics Inc is a company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-04
REV
Q2 2021Est.ActualSurprise
EPS-0.270-0.450 -0.1800
REV8.530M6.462M-2.068M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CEMIChembio Diagnostics-3%74.1M

Chembio Diagnostics Questions & Anwsers

Q

How do I buy Chembio Diagnostics (CEMI) stock?

A

You can purchase shares of Chembio Diagnostics (NASDAQ: CEMI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Chembio Diagnostics's (CEMI) competitors?

Q

What is the target price for Chembio Diagnostics (CEMI) stock?

A

The latest price target for Chembio Diagnostics (NASDAQ: CEMI) was reported by Benchmark on June 17, 2020. The analyst firm set a price target for 0.00 expecting CEMI to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Chembio Diagnostics (CEMI)?

A

The stock price for Chembio Diagnostics (NASDAQ: CEMI) is $2.59 last updated Fri Sep 24 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Chembio Diagnostics (CEMI) pay a dividend?

A

There are no upcoming dividends for Chembio Diagnostics.

Q

When is Chembio Diagnostics (NASDAQ:CEMI) reporting earnings?

A
Chembio Diagnostics’s Q3 earnings are confirmed for after-market on November 4, 2021.
Q

Is Chembio Diagnostics (CEMI) going to split?

A

There is no upcoming split for Chembio Diagnostics.

Q

What sector and industry does Chembio Diagnostics (CEMI) operate in?

A

Chembio Diagnostics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.